Open access · CC-BY
via OpenAlex
Chemotherapy-induced acceleration of DNA methylation-based biological age in breast cancer
Drew Robert Nannini, Rene Cortese, Christopher D VonTungeln, Gerhard Carl Hildebrandt
Epigenetics · 2024 · ▲ 9 citations
Abstract
Breast cancer is the most common cancer diagnosed in women and is often treated with chemotherapy. Although previous studies have demonstrated increasing biological age in patients who receive chemotherapy, evaluation of this association with DNA methylation-based markers of biological ageing may provide novel insight into the role of chemotherapy on the ageing process. We therefore sought to investigate the association between chemotherapy and markers of biological ageing as estimated from DNA methylation in women with breast cancer. DNA methylation profiling was performed on peripheral blood collected from 18 patients before and after the first cycle of chemotherapy using the Infinium HumanMethylation450 BeadChip. Six markers of biological age acceleration were estimated from DNA methylation levels. Multiple linear regression analyses were performed to evaluate the association between each metric of biological age acceleration and chemotherapy. After adjusting for chronological age and race, intrinsic epigenetic age acceleration (p = 0.041), extrinsic epigenetic age acceleration (p = 0.050), PhenoAge acceleration (p = 0.001), GrimAge acceleration (p < 0.001), and DunedinPACE (p = 0.006) were significantly higher and telomere(definition) length (p = 0.027) was significantly lower following the first cycle of chemotherapy compared to before treatment initiation. These results demonstrate greater biological ageing as estimated from DNA methylation following chemotherapy in women with breast cancer. Our findings illustrate that cytotoxic therapies may modulate the ageing process among breast cancer patients and may also have implications for age-related health conditions in cancer survivors.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1080/15592294.2024.2360160
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Nannini, D.R., Cortese, R., VonTungeln, C.D., & Hildebrandt, G.C. (2024). Chemotherapy-induced acceleration of DNA methylation-based biological age in breast cancer. <em>Epigenetics</em>. https://doi.org/10.1080/15592294.2024.2360160
Vancouver
Nannini DR, Cortese R, VonTungeln CD, Hildebrandt GC. Chemotherapy-induced acceleration of DNA methylation-based biological age in breast cancer. Epigenetics. 2024. doi:10.1080/15592294.2024.2360160.
BibTeX
@article{drew2024Chemot,
title = {Chemotherapy-induced acceleration of DNA methylation-based biological age in breast cancer},
author = {Drew Robert Nannini and Rene Cortese and Christopher D VonTungeln and Gerhard Carl Hildebrandt},
journal = {Epigenetics},
year = {2024},
doi = {10.1080/15592294.2024.2360160},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Scientific Reports 2025
Open access · CC-BY
Epigenetic aging acceleration among World Trade Center-exposed community members
GeroScience 2026
Open access · CC-BY
p16INK4a and DNA methylation clocks in women treated with chemotherapy for early breast cancer
AIDS 2023
Preprint · OA
Differences in epigenetic age by HIV status among patients with a non-AIDS defining cancer
Environmental Epidemiology 2024
Open access · CC-BY
Associations between use of chemical hair products and epigenetic age: Findings from the Sister Study
International Journal of Cancer 2026
Open access · CC-BY
Epigenetic Markers of Cell Division and Ageing in Relation to Breast Cancer Survival
International journal of cancer 2026
Open access · OA